发明名称 Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom
摘要 The present invention relates to synthetic, consensus foot-and-mouth disease virus (FMDV) immunogenic proteins and nucleic acid molecule encoding such proteins, to vaccines against FMDV, to methods for inducing immune responses against FMVD, to methods for distinguishing between individuals infected with FMDV versus those vaccinated against FMDV, and methods of prophylactically and/or therapeutically immunizing individuals against FMDV.
申请公布号 US2016045589(A1) 申请公布日期 2016.02.18
申请号 US201414774356 申请日期 2014.03.17
申请人 WEINER David B.;MUTHUMANI Karuppiah;YAN Jian;SARDESAI Niranjan Y.;THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA ;INOVIO PHARMACEUTICALS, INC. 发明人 WEINER David;YAN Jian;MUTHUMANI Karuppiah;SARDESAI Niranjan Y.
分类号 A61K39/135;C12N7/00;C07K14/005 主分类号 A61K39/135
代理机构 代理人
主权项 1. A nucleic acid molecule comprising sequences encoding one or more sequences selected from the group consisting of: a) a leader sequence linked to coding sequence for viral protein VP4 linked at its C terminus to coding sequence for a protease cleavage site linked at its C terminus to coding sequence for viral protein VP2 linked at its C terminus to coding sequence for a protease cleavage site linked at its C terminus to coding sequence for viral protein VP3 linked at its C terminus to coding sequence for a protease cleavage site linked to coding sequence for viral protein VP1 linked at its C terminus to coding sequence for a protease cleavage site linked to coding sequence for viral protein 2A; b) a leader sequence linked to coding sequence for viral protein VP2 linked at its C terminus to coding sequence for a protease cleavage site linked at its C terminus to coding sequence for viral protein VP3 linked at its C terminus to coding sequence for a protease cleavage site linked to coding sequence for viral protein VP1 linked at its C terminus to coding sequence for a protease cleavage site linked to coding sequence for viral protein 2A; c) a leader sequence linked to coding sequence for viral protein VP4 linked at its C terminus to coding sequence for a protease cleavage site linked at its C terminus to coding sequence for viral protein VP2 linked at its C terminus to coding sequence for a protease cleavage site linked at its C terminus to coding sequence for viral protein VP3 linked at its C terminus to coding sequence for a protease cleavage site linked to coding sequence for viral protein VP1; and d) a leader sequence linked to coding sequence for viral protein VP2 linked at its C terminus to coding sequence for a protease cleavage site linked at its C terminus to coding sequence for viral protein VP3 linked at its C terminus to coding sequence for a protease cleavage site linked to coding sequence for viral protein VP1.
地址 US